Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Stroke: Introduction and Types01:29

Stroke: Introduction and Types

75
A stroke is an acute neurological event caused by the sudden disruption of cerebral blood flow, leading to rapid loss of neuronal function. Neurons depend on continuous oxygen and glucose supply, so even brief interruptions can cause irreversible injury within minutes. Strokes are classified into ischemic and hemorrhagic types.Ischemic StrokeIschemic strokes are most common and occur due to arterial occlusion, depriving brain tissue of oxygen and nutrients. This leads to energy failure, ionic...
75
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

57
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
57
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

74
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
74
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

41
A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
41
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

57
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
57
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

35
A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
35

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Differentiating effective salvage from ineffective delayed compensation in anterior circulation stroke: a dynamic quantitative collateral index.

Frontiers in medicine·2026
Same author

MRI-based radiomics-deep learning model for preoperative pathogen prediction in perianal abscesses.

Frontiers in medicine·2026
Same author

Multimodal Fusion Network with Information Bottleneck Mamba and Intervention Enhancement for Retinal Disease Diagnosis.

IEEE journal of biomedical and health informatics·2026
Same author

Multimodal Magnetic Resonance Imaging in Diabetic Kidney Disease: From Pathophysiological Insights to Clinical Applications.

Diagnostics (Basel, Switzerland)·2026
Same author

Advanced High-Entropy Biomaterials (HEBs).

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Evaluation of cartilaginous endplate degeneration with histogram features of multiple parameters in UTE MRI.

BMC medical imaging·2026
Same journal

Cationic nanotrap curbs UVB-induced cutaneous photodamage via exosomal cfNA capture.

Biomaterials·2026
Same journal

A protein-initiated polymerization cascade enables a self-eliminating powder tissue adhesive for diabetic ulcer repair.

Biomaterials·2026
Same journal

Oral colon-targeted micro-nano formulation engineered in microfluid for synergistic therapy of inflammatory bowel disease.

Biomaterials·2026
Same journal

Manganese@Gold cluster-coordinated covalent organic frameworks-based artificial metalloenzymes with cascade biocatalysis and amplified systemic stimulation to combat malignant tumor metastasis.

Biomaterials·2026
Same journal

Remodeling TME via feedback-driven photothermal-ferroptosis-immune cascade.

Biomaterials·2026
Same journal

Corrigendum to "Photodynamic therapy produces enhanced efficacy of antitumor immunotherapy by simultaneously inducing intratumoral release of sorafenib" [Biomaterials 2020, 240, 119845].

Biomaterials·2026
関連記事をすべて見る

関連する実験動画

Updated: May 6, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

15.4K

虚血性脳卒中におけるナノメディシン

Lan Luo1, Meiqi Chang2, Ying Wang3

  • 1University of Shanghai for Science and Technology, Shanghai, 200093, PR China.

Biomaterials
|December 23, 2025
PubMed
まとめ
この要約は機械生成です。

ナノメディシンは、早期の脳卒中診断と治療に高度なソリューションを提供し、現在の限界を克服します。このレビューは、ナノテクノロジーに焦点を当てています。

キーワード:
診断画像虚血性脳卒中ナノドラッグデリバリーナノメディシンナノプローブ

さらに関連する動画

Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia
14:53

Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia

Published on: June 26, 2020

10.9K
Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research
07:34

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research

Published on: December 15, 2023

3.2K

関連する実験動画

Last Updated: May 6, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

15.4K
Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia
14:53

Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia

Published on: June 26, 2020

10.9K
Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research
07:34

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research

Published on: December 15, 2023

3.2K

科学分野:

  • 生体医工学; 材料科学; 神経学

背景:

  • 高齢化とライフスタイルの変化により、世界的に脳卒中の発生率が増加しています。現在の脳卒中の診断と治療法には、重大な限界があります。ナノメディシンは、これらの課題に対処するための有望なアプローチを提示します。

研究 の 目的:

  • 虚血性脳卒中の早期診断と治療の進歩におけるナノメディシンの役割をレビューすること。脳卒中管理におけるナノマテリアルの特性、設計戦略、および応用について議論すること。脳卒中診断治療におけるナノメディシンの臨床応用への課題と将来の方向性を探ること。

主な方法:

  • 虚血性脳卒中におけるナノメディシンの応用に関する文献レビュー。診断および治療目的のためのナノマテリアルの組成と表面設計の分析。イメージング、ドラッグデリバリー、および多機能診断治療のためのナノプラットフォームの検討。

主要な成果:

  • ナノマテリアルは、脳卒中イメージングの向上に効果的な造影剤として機能します。ナノキャリアは、治療効果の向上に標的ドラッグデリバリーを促進します。多機能ナノシステムは、脳卒中管理のための統合された診断および治療能力を提供します。

結論:

  • ナノメディシンは、虚血性脳卒中の診断治療に革命をもたらす大きな可能性を秘めています。臨床応用の課題に対処することは、脳卒中治療におけるナノテクノロジーを採用するために不可欠です。将来の研究は、患者の転帰と臨床応用の改善のためにナノメディシンを最適化することに焦点を当てるべきです。